Eli Lilly Agrees to Acquire Merida for Up to $2.875 Billion
LLY Lilly(Eli) & Co
$1143.12 +0.02%
View chart & analysis → - 1Eli Lilly (LLY) agrees to acquire Merida Biosciences for up to $2.875 billion in cash
- 2If completed, the deal would mark Lilly's 13th acquisition of 2026, with closure expected in Q4
- 3The move aims to strengthen its autoimmune and allergy portfolio, including Graves' disease candidate MER511
Source Barrons.com +8 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.